poisar

Stocks · News reference

Actuate Therapeutics Reports Third Quarter 2026 Financial Results

Fiscal.ai

Actuate Therapeutics reported its financial results for the third quarter of 2026, highlighting a reduction in operating losses compared to the same period last year.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARSEC EDGAR

    8-K filing — ACTUATE THERAPEUTICS, INC. (ACTU)

    Filed: 2026-10-30 AccNo: 0001683168-26-008193 Size: 207 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing